Organon (OGN): Looks good. There is also a very nice...

Followed By	2
Posts	664
Boards Moderated	0
Alias Born	10/16/2019

LordDarley

Monday, June 07, 2021 11:50:57 AM

Re: DewDiligence post# 2

Looks good.
There is also a very nice analysis on seeking Alpha. Shows pros and cons, and is professional quality IMHO. Much more detail than the Barron's article.

Recent OGN News

Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd) • Business Wire • 08/17/2022 11:30:00 AM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 08/09/2022 11:54:28 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 08/09/2022 11:53:28 PM
Quarterly Report (10-q) • Edgar (US Regulatory) • 08/05/2022 10:03:22 AM
Organon Reports Results for the Second Quarter Ended June 30, 2022 • Business Wire • 08/04/2022 11:30:00 AM
オルガノンとサークル・バイオメディカルが非ホルモン性オンデマンド避妊薬の治験薬候補に関する共同研究・ライセンス契約を締結 • Business Wire • 08/02/2022 04:23:00 AM
Organon et Cirqle Biomedical signent un accord de recherche collaborative et de licence pour un contraceptif candidat expérimental, non hormonal et à la demande • Business Wire • 07/28/2022 11:29:00 PM
Organon und Cirqle Biomedical schließen Forschungskooperation und Lizenzvertrag für einen nicht-hormonellen, nach Bedarf anzuwendenden Verhütungsmittelkandidaten • Business Wire • 07/28/2022 04:52:00 PM
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate • Business Wire • 07/28/2022 11:30:00 AM
Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022 • Business Wire • 07/21/2022 11:30:00 AM
Cognizant Teams Up with Organon to Speed Delivery of Pharmaceutical Products and Improve Women's Healthcare • PR Newswire (US) • 07/21/2022 10:30:00 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 07/12/2022 11:01:35 AM
Daré Bioscience Announces Closing of Global License Agreement with Organon to Commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis • GlobeNewswire Inc. • 06/30/2022 12:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:43:57 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:43:01 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:42:11 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:41:04 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:40:08 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:38:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:36:43 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:34:57 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:34:17 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:33:07 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/14/2022 11:31:36 PM
Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates • Business Wire • 06/13/2022 12:30:00 PM

More OGN News

InvestorsHub NewsWire

FEATURED Electromedical Technologies Announces Financial and Operational Highlights for the Three and Six Months Ended June 30, 2022 • Aug 18, 2022 7:12 AM

PSYC Appoints COO for Wholly Owned Subsidiary, Spotlight Media Corp. • PSYC • Aug 17, 2022 8:30 AM

ResGreen Group Adds Wireless Stacklights to its Line-Up of Industrial Automation Devices • RGGI • Aug 17, 2022 7:41 AM

GBT Filed a Non-Provisional Patent Application Seeking to Protect the Automatic Correction of Integrated Circuits Connectivity Mismatches • GTCH • Aug 16, 2022 4:56 PM

InnerScope Hearing Technologies (OTC: INND) Announces FDA Has Released The Final Rule For OTC Hearing Aids • INND • Aug 16, 2022 11:29 AM

FDCTech's Quarterly Release for the Second Quarter (FY22 Q2) Results • FDCT • Aug 16, 2022 9:42 AM

Fastbase (OTC:FBSE) Explodes Data Research Space • FBSE • Aug 16, 2022 9:15 AM

WaterPure International Inc (OTCMKTS: WPUR) Heating Up after Co Announces it is Exploring Multiple Merger & Acquisition Opportunities • INTK • Aug 16, 2022 9:00 AM

PSYC Enters MOU to Acquire Technical420, LLC for $2.25M in Accretive Transaction • PSYC • Aug 16, 2022 8:30 AM

Branded Legacy, Inc. Announces Removal of "Yield" Sign on OTC Markets Stock Quotes • BLEG • Aug 16, 2022 8:30 AM

HealthLynked Reports Second Quarter 2022 Results • HLYK • Aug 16, 2022 8:00 AM

XCPCNL Business Services Announces Signing of Reverse Merger Acquisition Agreements with Centiment Capital Holdings • XCPL • Aug 16, 2022 7:15 AM

ILUS Confirms Its Second Quarter of 2022 Results, Including a 553% Revenue Increase Over Its Previous Quarter, to $19,677,222 • ILUS • Aug 15, 2022 2:52 PM

S.E.C.-registered HYUNDAI brand consumer technologies enters the U.S. market with a $100 million stocks and bond offering Aug 15, 2022 12:04 PM

Branded Legacy, Inc. Reduces Issued and Outstanding Shares By 46% • BLEG • Aug 15, 2022 8:30 AM

Green Battery Minerals Receives Assays from Drilling into Graphite Outcrops on Zone 1. Intersecting 19.5 metres of 35.52% Grade Graphite and 51.20 meters of 22.61% Grade Graphite. • GEM • Aug 12, 2022 6:07 PM

Start posting your company's news
Only $200 per official company press release!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Quotes:

IHub:

More OGN News

Detailed Quote